当前位置: X-MOL 学术J. Clin. Invest. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia
The Journal of Clinical Investigation ( IF 15.9 ) Pub Date : 2017-08-07 , DOI: 10.1172/jci89812
James S. Ware , Louise V. Wain , Sarath K. Channavajjhala , Victoria E. Jackson , Elizabeth Edwards , Run Lu , Keith Siew , Wenjing Jia , Nick Shrine , Sue Kinnear , Mahli Jalland , Amanda P. Henry , Jenny Clayton , Kevin M. O’Shaughnessy , Martin D. Tobin , Victor L. Schuster , Stuart Cook , Ian P. Hall , Mark Glover

Thiazide diuretics are among the most widely used treatments for hypertension, but thiazide-induced hyponatremia (TIH), a clinically significant adverse effect, is poorly understood. Here, we have studied the phenotypic and genetic characteristics of patients hospitalized with TIH. In a cohort of 109 TIH patients, those with severe TIH displayed an extended phenotype of intravascular volume expansion, increased free water reabsorption, urinary prostaglandin E2 excretion, and reduced excretion of serum chloride, magnesium, zinc, and antidiuretic hormone. GWAS in a separate cohort of 48 TIH patients and 2,922 controls from the 1958 British birth cohort identified an additional 14 regions associated with TIH. We identified a suggestive association with a variant in SLCO2A1, which encodes a prostaglandin transporter in the distal nephron. Resequencing of SLCO2A1 revealed a nonsynonymous variant, rs34550074 (p.A396T), and association with this SNP was replicated in a second cohort of TIH cases. TIH patients with the p.A396T variant demonstrated increased urinary excretion of prostaglandin E2 and metabolites. Moreover, the SLCO2A1 phospho-mimic p.A396E showed loss of transporter function in vitro. These findings indicate that the phenotype of TIH involves a more extensive metabolic derangement than previously recognized. We propose one mechanism underlying TIH development in a subgroup of patients in which SLCO2A1 regulation is altered.

中文翻译:

噻嗪类低钠血症患者的表型和药物遗传学评价

噻嗪类利尿剂是最广泛使用的高血压治疗方法之一,但是对噻嗪类引起的低钠血症(TIH)(一种临床上显着的不良反应)知之甚少。在这里,我们研究了TIH住院患者的表型和遗传特征。在109名TIH患者队列中,患有严重TIH的患者表现出血管内体积扩展的扩展表型,游离水重吸收增加,尿中前列腺素E 2排泄,血清氯,镁,锌和抗利尿激素排泄减少。来自1958年英国出生队列的48名TIH患者和2,922名对照的另一个队列中的GWAS确定了另外14个与TIH相关的区域。我们发现与SLCO2A1中的变体存在暗示性关联,其在远端肾单位中编码前列腺素转运蛋白。对SLCO2A1的重新测序揭示了一个非同义的变体rs34550074(p.A396T),并且在第二批TIH病例中复制了与此SNP的关联。具有p.A396T变体的TIH患者表现出前列腺素E 2和代谢产物的尿排泄增加。此外,SLCO2A1磷酸模拟p.A396E在体外显示转运蛋白功能丧失。这些发现表明,TIH的表型涉及比以前公认的更广泛的代谢紊乱。我们提出了SLH2A1调节改变的患者亚组TIH发育的基础机制。
更新日期:2017-09-08
down
wechat
bug